Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer
Clinical trial NCT04073550 · UNKNOWN
Trial details
- NCT number
- NCT04073550
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2021-07-31
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.